Discovery and validation of pyrrolopyrimidine-based VEGFR2 inhibitors targeting tumor angiogenesis via structure-based virtual screening, quantum chemical analysis, and in vitro assays
Journal of Computer-Aided Molecular Design · 2025
DOI: 10.1007/s10822-025-00685-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Computer-Aided Molecular Design, 2025. Verfasst von Ahmed I Foudah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, 11942, Alkharj, Saudi Arabia. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Pyrimidines, Angiogenesis Inhibitors, Pyrroles. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Prince Sattam Bin Abdulaziz University.
Abstract (Originalsprache)
Tumor angiogenesis, largely driven by VEGFR2 signalling, is a critical hallmark of cancer progression. In this study, we employed a structure-based virtual screening approach of pyrrolopyrimidine analogs from a natural product database, combined with density functional theory (DFT), molecular docking, and molecular dynamics (1 μs) simulations, to identify potential VEGFR2 inhibitors. Binding free energy (MM-GBSA) calculations were used to refine candidate selection. Three top-ranking compounds, CNP0279613, CNP0102100, and CNP0004587, were identified, with CNP0279613 showing the most favourable stability and binding affinity. Biophysical validation using isothermal titration calorimetry confirmed strong binding of CNP0279613 to VEGFR2, while in vitro MTT assays in HUVEC cells demonstrated its superior anti-angiogenic activity compared to the other candidates. Notably, its inhibitory effect was comparable to that of Ramucirumab, an FDA-approved VEGFR2 inhibitor. Together, these computational and experimental findings highlight CNP0279613 as a promising lead scaffold for the development of next-generation anti-angiogenic therapies and warrant further optimization and in vivo evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, 11942, Alkharj, Saudi Arabia.
- Department of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, 11942, Alkharj, Saudi Arabia. a.alam@psau.edu.sa.
Förderung
- Prince Sattam Bin Abdulaziz University
Zitieren
APA
Foudah, A. I., Sharma, P., & Alam, A. (2025). Discovery and validation of pyrrolopyrimidine-based VEGFR2 inhibitors targeting tumor angiogenesis via structure-based virtual screening, quantum chemical analysis, and in vitro assays. Journal of Computer-Aided Molecular Design. https://doi.org/10.1007/s10822-025-00685-2
Vancouver
Foudah AI, Sharma P, Alam A. Discovery and validation of pyrrolopyrimidine-based VEGFR2 inhibitors targeting tumor angiogenesis via structure-based virtual screening, quantum chemical analysis, and in vitro assays. Journal of Computer-Aided Molecular Design. 2025. doi:10.1007/s10822-025-00685-2
BibTeX
@article{Foudah2025,
author = {Foudah, Ahmed I and Sharma, Pradeep and Alam, Aftab},
title = {Discovery and validation of pyrrolopyrimidine-based VEGFR2 inhibitors targeting tumor angiogenesis via structure-based virtual screening, quantum chemical analysis, and in vitro assays},
journal = {Journal of Computer-Aided Molecular Design},
year = {2025},
doi = {10.1007/s10822-025-00685-2}
}
EUVIMED